Modified Ipswich procedure: Patient‐perceived benefit and surgical outcomes in a series of ten patients | Zendy

Staniszewski B. | Zendy; Green R. | Zendy; Sharpe G. | Zendy; White P. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Modified Ipswich procedure: Patient‐perceived benefit and surgical outcomes in a series of ten patients

Author(s) -

Staniszewski B.,

Green R.,

Sharpe G.,

White P.

Publication year - 2017

Publication title -

clinical otolaryngology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.914

H-Index - 68

eISSN - 1749-4486

pISSN - 1749-4478

DOI - 10.1111/coa.12891

Subject(s) - medicine , otorhinolaryngology , medical school , family medicine , general hospital , oral medicine , dentistry , medical education , surgery

1. Forastiere AA, Ang KK, Brizel D, et al. Head and neck cancers. J Natl Compr Canc Netw. 2008;6:646-695. 2. Busch CJ, Tribius S, Schafhausen P, Knecht R. The current role of systemic chemotherapy in the primary treatment of head and neck cancer. Cancer Treat Rev. 2015;41:217-221. 3. Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31:845-852. 4. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705-1715. 5. Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695-1704. 6. Stromberger C, Knecht R, Raguse JD, et al. Standard or split TPF induction chemotherapy followed by bioradiation: ICRAT randomized phase II study. 2016. ASCO Meeting Abstracts 34 (15_suppl):6035. 7. Hitt R, Grau JJ, Lopez-Pousa A, et al. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann. Oncol. 2014;25:216-225. 8. Blanchard P, Bourhis J, Lacas B, et al., Meta-Analysis of Chemotherapy in H, Neck Cancer IPCG. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol. 2013;31:2854-2860. 9. Adelstein DJ, Moon J, Hanna E, et al. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: a Southwest Oncology Group phase II trial (S0216). Head Neck. 2010;32:221-228. 10. Pfister DG, Spencer S, Brizel DM, et al. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015;13:847-855; quiz 856.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research